Yu J, Han L, Yang F, Zhao M, Zhou H, Hu L. SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy. Bioengineered. 2022;13:14125-14137 pubmed publisher

Kumar S, Ramamurthy C, Choudhary D, Sekar A, Patra A, Bhavesh N, et al. Contrasting roles for G-quadruplexes in regulating human Bcl-2 and virus homologues KSHV KS-Bcl-2 and EBV BHRF1. Sci Rep. 2022;12:5019 pubmed publisher

Zhan H, Qin R, Li Y, Liu M, Gan L. TFEB promotes BCL-2 expression by upregulating its promoter activity in the t(6;11) translocation renal cell carcinomas. Am J Transl Res. 2021;13:8804-8818 pubmed

Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, et al. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Theranostics. 2020;10:7656-7670 pubmed publisher

Kavazović I, Han H, Balzaretti G, Slinger E, Lemmermann N, ten Brinke A, et al. Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biol. 2020;18:e3000648 pubmed publisher

Kim S, Ko D, Lee Y, Jang S, Lee Y, Lee I, et al. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4. Sci Rep. 2019;9:10003 pubmed publisher

Dutta D, Debnath M, Muller D, Paul R, Das T, Bessi I, et al. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. Nucleic Acids Res. 2018;46:5355-5365 pubmed publisher

Maiti S, Saha P, Das T, Bessi I, Schwalbe H, Dash J. Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells. Bioconjug Chem. 2018;29:1141-1154 pubmed publisher

Sun Y, Lu F, Han X, Ji M, Zhou Y, Zhang A, et al. MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1. Oncotarget. 2016;7:25276-90 pubmed publisher

Wang X, Zhou M, Fu Y, Sun T, Chen J, Qin X, et al. RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2. PLoS ONE. 2016;11:e0152142 pubmed publisher

Zhao R, Han C, Eisenhauer E, Kroger J, Zhao W, Yu J, et al. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells. Mol Cancer Res. 2014;12:370-80 pubmed publisher

Heckman C, Mehew J, Ying G, Introna M, Golay J, Boxer L. A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. J Biol Chem. 2000;275:6499-508 pubmed